Characterization of endocytic uptake of MK2-inhibitor peptides

Peptide-Mediated Inhibition of Mitogen-Activated Protein Kinase–Activated Protein Kinase–2 Ameliorates Bleomycin-Induced Pulmonary Fibrosis

(2013) Ragini Vittal et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: Toward an understanding of its selectivity for cancer cells

(2013) Marie-Lise Jobin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Cell-penetrating Peptides Split into Two Groups Based on Modulation of Intracellular Calcium Concentration

(2012) Annely Lorents et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape

(2012) Fabrizio Salomone et al.   JOURNAL OF CONTROLLED RELEASE

Cell entry of cell penetrating peptides: tales of tails wagging dogs

(2012) Arwyn T. Jones et al.   JOURNAL OF CONTROLLED RELEASE

Transient Focal Membrane Deformation Induced by Arginine-rich Peptides Leads to Their Direct Penetration into Cells

(2012) Hisaaki Hirose et al.   MOLECULAR THERAPY

Cell-penetrating peptides: breaking through to the other side

(2012) Erez Koren et al.   TRENDS IN MOLECULAR MEDICINE

Entry of Human Papillomavirus Type 16 by Actin-Dependent, Clathrin- and Lipid Raft-Independent Endocytosis

(2012) Mario Schelhaas et al.   PLoS Pathogens

Cell-penetrating peptides can confer biological function: Regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides

(2011) Jamie L. Brugnano et al.   JOURNAL OF CONTROLLED RELEASE

Peptide Inhibitors of MK2 Show Promise for Inhibition of Abdominal Adhesions

(2011) Brian C. Ward et al.   JOURNAL OF SURGICAL RESEARCH

Molecular partners for interaction and cell internalization of cell-penetrating peptides: how identical are they?

(2011) Astrid Walrant et al.   Nanomedicine

Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo

(2011) Akihito Muto et al.   VASCULAR PHARMACOLOGY

Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells

(2010) Isabel D. Alves et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model

(2010) Luciana B. Lopes et al.   JOURNAL OF VASCULAR SURGERY

Mechanisms of Endocytosis

(2009) Gary J. Doherty et al.   Annual Review of Biochemistry

Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor

(2009) Luciana B. Lopes et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction

(2009) Jacob M. Gump et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Translocation and Endocytosis for Cell-penetrating Peptide Internalization

(2009) Chen-Yu Jiao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD

(2009) Catherine L. Watkins et al.   JOURNAL OF CONTROLLED RELEASE

Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce

(2009) Brian Ward et al.   JOURNAL OF PEPTIDE SCIENCE

MK2 inhibitor peptide reduces adhesion formation without affecting colonic anastomotic healing

(2009) Sandra L. Kavalukas et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Intracellulartransduction using cell-penetrating peptides

(2009) Rupa Sawant et al.   Molecular BioSystems

Transduction of adenovirus vectors modified with cell-penetrating peptides

(2009) Yusuke Eto et al.   PEPTIDES

siRNA delivery using peptide transduction domains

(2009) Akiko Eguchi et al.   TRENDS IN PHARMACOLOGICAL SCIENCES